Efficacy of Vernakalant in the conversion of atrial fibrillation in critical illness

Trial Profile

Efficacy of Vernakalant in the conversion of atrial fibrillation in critical illness

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 Aug 2015

At a glance

  • Drugs Vernakalant (Primary) ; Amiodarone
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms VINCES
  • Most Recent Events

    • 20 Aug 2015 Status changed from recruiting to discontinued, as reported by Netherlands Trial Register (NTR4213)
    • 19 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top